Literature DB >> 31169205

Oral submucous fibrosis: An enigmatic morpho-insight.

Alka Harish Hande1, Minal S Chaudhary1, Madhuri N Gawande1, Amol R Gadbail1, Prajakta R Zade1, Shree Bajaj1, Swati K Patil1, Satyajit Tekade2.   

Abstract

Oral submucous fibrosis (OSMF) is a chronic progressive, scarring disease affecting oral, oropharyngeal, and sometimes the esophageal mucosa. It is characterized by the progressive fibrosis of the submucosal tissue. The pathogenesis of OSMF has been directly related to the habit of chewing areca nut and its commercial preparation, which is widespread in Indian subcontinent and Southeast Asia. The areca nut has been classified as a "group one human carcinogen." Oral squamous cell carcinoma in the background of OSMF is one of the most common malignancies in South and Southeast Asian countries. Malignant transformation has been reported in 7%-12% cases of OSMF. Histopathological spectrum of OSMF includes the apparent alterations observed in the epithelium and connective tissue. Epithelial atrophy and sometimes epithelial hyperplasia with or without dysplasia are the peculiar alterations seen in the epithelium. In the connective tissue, there is extracellular matrix remodeling which results in excessive collagenization. Further cross-linking of collagen leads to hyalinization which makes the collagen resistant to proteolysis. Owing to fibrosis in the connective tissue, there is narrowing of blood vessels which further results in compromised blood supply to the local tissue milieu, that is, hypoxia. This tissue hypoxia elicits angiogenesis which may result in the malignant transformation of OSMF. Perpetual irritation of areca nut and its constituents to the oral mucosa leads to upregulation of pro-inflammatory cytokines and further juxtaepithelial inflammation. Thus, these coordinated reactions in epithelium and connective tissue leads the OSMF toward malignant transformation.

Entities:  

Keywords:  Areca nut; oral squamous cell carcinoma; oral submucous fibrosis

Mesh:

Year:  2019        PMID: 31169205     DOI: 10.4103/jcrt.JCRT_522_17

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  7 in total

1.  New Insights for Consummate Diagnosis and Management of Oral Submucous Fibrosis Using Reactive and Reparative Fibrotic Parameter Derived Algorithm.

Authors:  Ramya Ramadoss; Rajkumar Krishnan; V Vasanthi; Divya Bose; R Vijayalakshmi; Rajashree Padmanabhan; Balakumar Subramanian
Journal:  J Pharm Bioallied Sci       Date:  2021-06-05

Review 2.  Risk of liver disease in areca nut habitual: A systematic review.

Authors:  Suwarna B Dangore Khasbage; Rahul R Bhowate; Nazli Khatib
Journal:  J Oral Maxillofac Pathol       Date:  2022-03-31

3.  Oral squamous cell carcinoma in coca chewers from a north region of Argentina: A case series and review of literature.

Authors:  Ignacio Molina-Ávila; Andrea Arellano Rojas; Gerardo Gilligan; Karina Cordero-Torres
Journal:  J Oral Maxillofac Pathol       Date:  2022-02-28

4.  Fucoidan-Mediated Inhibition of Fibrotic Properties in Oral Submucous Fibrosis via the MEG3/miR-181a/Egr1 Axis.

Authors:  Chih-Yuan Fang; Szu-Han Chen; Chun-Chung Huang; Yi-Wen Liao; Shih-Chi Chao; Cheng-Chia Yu
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-05

5.  Management and Prognosis of Physical Therapy for the Post-Surgical Sequelae of Metastatic Cervical Lymphadenopathy.

Authors:  Sakina S Saifee; Shubhangi P Patil; Rupali B Thorat; Shivani S Lalwani; Tasneem M Lakkadsha
Journal:  Cureus       Date:  2022-08-04

6.  Adipose-Derived Stem Cell-Derived Extracellular Vesicles Inhibit the Fibrosis of Fibrotic Buccal Mucosal Fibroblasts via the MicroRNA-375/FOXF1 Axis.

Authors:  Bin Han; Yanhui Zhang; Yuxia Xiao; Bohong Shi; Hong Wu; Desheng Liu
Journal:  Stem Cells Int       Date:  2021-06-22       Impact factor: 5.443

Review 7.  Genetic Susceptibility and Protein Expression of Extracellular Matrix Turnover-Related Genes in Oral Submucous Fibrosis.

Authors:  Ru-Hsiu Cheng; Yi-Ping Wang; Julia Yu-Fong Chang; Yu-Hwa Pan; Mei-Chi Chang; Jiiang-Huei Jeng
Journal:  Int J Mol Sci       Date:  2020-10-30       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.